{
    "2019-01-08": [
        [
            {
                "time": "2019-01-08",
                "original_text": "Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "AXSM",
                        "AKRX",
                        "NVS",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Pfizer or Eli Lilly: Which Company Is More Cost Efficient?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Cost Efficient"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?",
                "features": {
                    "keywords": [
                        "Dogs of the Dow",
                        "ETFs",
                        "Success"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "index funds"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Pfizer or Eli Lilly: Which Company Has Better Margins?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Better Margins"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "3 Companies You Don't Realize You Rely On Every Day",
                "features": {
                    "keywords": [
                        "Companies",
                        "Rely On"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Pfizer or Eli Lilly: Whose Earnings Are Seeing Better Growth?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Earnings Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "New CEO",
                        "Investors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Pfizer",
                        "Pharma M&A"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Pfizer (PFE) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}